DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
September 13, 2023 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a...
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
June 20, 2023 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, June 20, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence (“AI”) healthcare company, is...
DiagnaMed Launches a Generative Artificial Intelligence Medical Chatbot, Dr. GenAI
June 15, 2023 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, June 15, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare company, is pleased to announce the launch of...
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
May 25, 2023 10:08 ET
|
DiagnaMed Holdings Corp.
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce the...
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
May 17, 2023 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce...
DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
May 10, 2023 07:30 ET
|
Diagnamed Holdings Corp.
TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce the...
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
May 03, 2023 07:30 ET
|
Diagnamed Holdings Corp.
TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce the...
DiagnaMed Announces Listing on OTCQB in the United States
April 11, 2023 07:30 ET
|
Diagnamed Holdings Corp.
TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health AI company, is pleased to announce that effective...
DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product
March 22, 2023 07:30 ET
|
Diagnamed Holdings Corp.
TORONTO, March 22, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a digital health AI company, is pleased to announce the addition of Dr. Bassma Ghali,...
DiagnaMed Announces Application for OTCQB Listing
March 09, 2023 07:30 ET
|
Diagnamed Holdings Corp.
Increasing awareness within the U.S. capital markets DiagnaMed focused on commercializing CERVAI™, its proprietary Brain Health AI Platform leveraging Generative AI TORONTO, March 09, 2023 (GLOBE...